on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Declares Position in Mural Oncology
The Vanguard Group, Inc. has disclosed its position regarding Mural Oncology plc, in line with Rule 8.3 of the Irish Takeover Panel Act. The disclosure, dated September 18, 2025, reveals Vanguard's significant stakeholding in Mural Oncology.
Vanguard controls 770,995 ordinary shares, equivalent to 4.46% of Mural Oncology's $0.01 ordinary shares. This stake surpasses the 1% threshold necessitating disclosure under Irish takeover regulations.
The document does not indicate involvement in any derivatives or other financial products tied to Mural Oncology shares. Additionally, there are no disclosed agreements, arrangements, or understandings influencing future transactions or voting rights pertaining to these holdings.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news